Health-Enhancing Adapted Physical Activity Program at "Mon Stade"

Summary

Introduction: Regular practice of exercise or physical activity (PA) is a recognized intervention as a determinant of good health acquisition, maintenance, or recovery for a large number of chronic pathologies. Nevertheless, few studies have evaluated adherence to an initial health-adapted PA (APA) program, and persistence of active behavior over the time in individuals with a chronic disease.

The aim of the study is to determine the brakes and levers associated with motivation and long-term compliance. In addition, the investigators aim to evaluate the cost-effectiveness of such program in term of care consumption. Finally, the investigators complete their interest for APA prescription from practitioners agreeing to enroll their patients in the present study.

Method: The investigators perform a prospective monocentric cohort, of 2024 patients affected of a chronic disease or long-term illness (LTI), enrolled from 2021 to 2024 (4 years, 506 per year), for a 16-week APA program, and followed 5 years with an annual fitness and habits of life and care consumption evaluation.

Conditions

• Exercise Therapy
• Behavior and Behavior Mechanisms
• Adherence, Patient
• Lifestyle, Sedentary
• Life Style
• Life Style, Healthy
• Cost-Benefit Analysis
• Prescriptions
• Physical Activity
• Adapted Physical Activity

Interventions

BEHAVIORAL

Adapted Physical Activity

A 16-week health-adapted physical activity program, individualized from baseline evaluation of participants including the specificities of their pathologies

Sponsors & Collaborators

• Laboratory MOVE, Faculty of Sport Sciences, University of Poitiers, France

  collaborator UNKNOWN

• Public Health Foundation of MGEN, France

  collaborator UNKNOWN

• General Mutual Insurance of National Education, France

  collaborator UNKNOWN

• Mon Stade Sports Medicine Centre

  lead OTHER

Principal Investigators

• Philippe Sosner, MD, PhD · Mon Stade Sports Medicine Center, Paris, France

Study Design

Allocation

NA

Purpose

PREVENTION

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2021-01-28

Primary Completion

2025-01-31

Completion

2030-12-31

Countries

• France

Study Locations